Patents Assigned to InteRNA Technologies B.V.
  • Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
    Publication number: 20150297626
    Abstract: The invention relates to the therapeutic use of a combination in a disease and condition associated with melanoma or a disease or a condition associated with activated BRAF pathway.
    Type: Application
    Filed: November 6, 2013
    Publication date: October 22, 2015
    Applicant: InteRNA Technologies B.V.
    Inventors: Rick Jan van Haastert, Petronella Innocentia van Noort, Grégoire Pierre André Prevost, Willemijn Maria Gommans, Roeland Quirinus Jozef Schaapveld, Matheus Maria De Gunst, Iman Johannes Schultz, Eugene Berezikov
  • DIAGNOSTIC PORTFOLIO AND ITS USES
    Publication number: 20150152499
    Abstract: A diagnostic portfolio comprising or consisting of isolated nucleic acid molecules, their complement and/or fragments thereof, said nucleic acid molecules, complements, equivalents and/or fragments thereof being represented by sequences comprising or consisting of sequences having at least 80% of sequence identity with SEQ ID NO:1-92, or 49-140 or derived thereof (i.e. groups a), b), c), d), e), f), g), h), i) or j) or subgroups thereof) and their uses.
    Type: Application
    Filed: July 3, 2013
    Publication date: June 4, 2015
    Applicant: InteRNA Technologies B.V.
    Inventors: Anton Jan Van Zonneveld, Jacques Duijs, Johan Kuiper, Thijs Jan Zweers, Johan Wouter Jukema, Eugene Berezikov
  • MiRNA for Treating Diseases and Conditions Associated with Neo-angiogenesis
    Publication number: 20140005251
    Abstract: The invention relates to the diagnostic and therapeutic uses of a miRNA molecule, an equivalent or a source thereof in a disease and condition associated with neo-angiogenesis.
    Type: Application
    Filed: July 2, 2013
    Publication date: January 2, 2014
    Applicant: InteRNA Technologies B.V.
    Inventors: Sanne WEIJZEN, Roeland Quirinus Jozef SCHAAPVELD, Meriem BOURAJJAJ, Rick Jan VAN HAASTERT, Arjan Willem GRIFFIOEN, Judith Rosina VAN BEIJNUM, Edwin Pieter Johan Gerard CUPPEN, Eugene BEREZIKOV, Andreas Alphons Franciscus Ludovicus VAN PUIJENBROEK, Willemijn Maria GOMMANS, Negar BABAE, Petronella Innocentia VAN NOORT
  • MiRNA AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH MELANOMA, OR IN DISEASES OR CONDITIONS ASSOCIATED WITH ACTIVATED BRAF PATHWAY
    Publication number: 20130109741
    Abstract: The invention relates to the diagnostic and therapeutic uses of a miRNA molecule, an equivalent or a source thereof in a disease and condition associated with melanoma or a disease or a condition associated with activated BRAF pathway.
    Type: Application
    Filed: January 4, 2013
    Publication date: May 2, 2013
    Applicants: Koninklijke Nederlandse Akademie van Wetenschappen, InteRNA Technologies B.V.
    Inventors: InteRNA Technologies B.V., Koninklijke Nederlandse Akademie van Wetensch
  • MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT
    Publication number: 20130072545
    Abstract: The invention relates to the diagnostic and therapeutic uses of a miRNA molecule or an equivalent thereof wherein a source of said miRNA molecule or equivalent thereof comprises at least 80 nucleotides and comprises a motif having at least 98% identity with the motif represented by SEQ ID NO:1 or a source thereof in a disease and condition associated with EMT (Epithelial to Mesenchymal Transition).
    Type: Application
    Filed: September 4, 2012
    Publication date: March 21, 2013
    Applicant: InteRNA Technologies B.V.
    Inventors: Roeland Quirinus Jozef Schaapveld, Gerardus Wilhelmus Christiaan Theodoor Verhaegh, Jacobus Antonius Schalken, Andreas Alphons Franciscus Ludovicus Van Puijenbroek, Willemjin Maria Gommans, Sanne Weijzen